NCT00443196View on ClinicalTrials.gov

Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

September 30, 2010

Conditions
AdenocarcinomaOvarian NeoplasmsFallopian Tube NeoplasmsPeritoneal Neoplasms
Interventions
PROCEDURE

MiCK Assay

Physician determined treatment

Trial Locations (1)

30342

Southeastern Gynecologic Oncology, Atlanta

Sponsors
All Listed Sponsors
lead

Pierian Biosciences

INDUSTRY